Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
pregnant or trying to get pregnant
Tirzepatide (Mounjaro/Zepbound) is a dual GIP/GLP-1 receptor agonist that has shown even greater weight loss than semaglutide in head-to-head trials
Persistent cloudiness or visible particles may indicate contamination or degradation
Blood sugar and insulin regulation Cagrilintide suppresses post-meal glucagon secretion, which helps stabilize blood glucose levels
Provided in oral capsule form, each compound is manufactured under cGMP-aligned standards and independently verified for purity and consistency
The coprimary end points were the relative change in body weight and a reduction of 5% or more in body weight from baseline to week 68 with cagrilintidesemaglutide as compared with placebo
US$ 21.90
US$ 24.56
US$ 23.92
US$ 28.80
